AIM AIM ImmunoTech Inc.
AIM ImmunoTech Inc. (AIM) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: September 17, 2026 , by Equels Thomas K .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Equels Thomas K | CEO & President | Buy | 24,000 | $0.21 | $5.0K | 126,822 | |
| Equels Thomas K | CEO & President | Buy | 11,000 | $0.21 | $2.3K | 102,822 | |
| Equels Thomas K | CEO & President | Buy | 22,000 | $0.22 | $4.9K | 91,822 | |
| Equels Thomas K | CEO & President | Buy | 5,900 | $0.22 | $1.3K | 69,822 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.